{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:33:21Z","timestamp":1784554401944,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1038\/sj.bdj.2009.5","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T11:23:47Z","timestamp":1232709827000},"page":"93-98","source":"Crossref","is-referenced-by-count":47,"title":["Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm"],"prefix":"10.1038","volume":"206","author":[{"given":"N.","family":"Malden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Beltes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,24]]},"reference":[{"key":"BFsjbdj20095_CR1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.joms.2007.04.004","volume":"65","author":"JJ Zahrowski","year":"2007","unstructured":"Zahrowski J J. Comment on the American Association of Oral and Maxillofacial Surgeons statement on bisphosphonates. J Oral Maxillofac Surg 2007; 65: 1440\u20131441.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj20095_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","volume":"14","author":"J Sarin","year":"2008","unstructured":"Sarin J, DeRossi S S, Akintoye S O. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis. Oral Dis 2008; 14: 277\u2013285.","journal-title":"Oral Dis"},{"key":"BFsjbdj20095_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002; 302: 1055\u20131061.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsjbdj20095_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","volume":"41","author":"IR Reid","year":"2007","unstructured":"Reid I R, Bolland M J, Grey A B. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 2007; 41: 318\u2013320.","journal-title":"Bone"},{"key":"BFsjbdj20095_CR5","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx R E, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567\u20131575.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj20095_CR6","first-page":"968","volume":"91","author":"MA Dimopoulos","year":"2006","unstructured":"Dimopoulos M A, Kastritis E, Anagnostopoulos A et al. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Haematologica 2006; 91: 968\u2013971.","journal-title":"Haematologica"},{"key":"BFsjbdj20095_CR7","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369\u2013376.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"BFsjbdj20095_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla S, Burr D, Cauley J et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479\u20131491.","journal-title":"J Bone Miner Res"},{"key":"BFsjbdj20095_CR9","doi-asserted-by":"crossref","unstructured":"American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc 2006; 137: 1144\u20131150.","DOI":"10.14219\/jada.archive.2006.0355"},{"issue":"6 Suppl 4","key":"BFsjbdj20095_CR10","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.seminoncol.2007.10.003","volume":"34","author":"RE Coleman","year":"2007","unstructured":"Coleman R E. Emerging strategies in bone health management for the adjuvant patient. Semin Oncol 2007; 34(6 Suppl 4): S11\u2013S16.","journal-title":"Semin Oncol"},{"key":"BFsjbdj20095_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","volume":"32","author":"Y Assouline-Dayan","year":"2002","unstructured":"Assouline-Dayan Y, Chang C, Greenspan A et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32: 94\u2013124.","journal-title":"Semin Arthritis Rheum"},{"key":"BFsjbdj20095_CR12","unstructured":"Corticosteroid-induced osteoporosis. In British National Formulary 54. Section 6.6:401. London: BMJ Publishing Group Ltd, 2007."},{"key":"BFsjbdj20095_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S8756-3282(01)00610-X","volume":"29","author":"D Patschan","year":"2001","unstructured":"Patschan D, Loddenkemper K, Buttgereit F. Molecular mechanisms of glucocorticoid-induced osteoporosis Bone 2001; 29: 498\u2013505.","journal-title":"Bone"},{"key":"BFsjbdj20095_CR14","unstructured":"Merck Sharp & Dohme Ltd. Fosamax. Section 5.2: pharmacokinetic properties. In Electronic Medicines Compendium. Available at http:\/\/www.emc.medicines.org.uk ."},{"key":"BFsjbdj20095_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2006.12.003","volume":"37","author":"SL Silverman","year":"2007","unstructured":"Silverman S L, Maricic M. Recent developments in bisphosphonate therapy. Semin Arthritis Rheum 2007; 37: 1\u201312.","journal-title":"Semin Arthritis Rheum"},{"key":"BFsjbdj20095_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/0266-4356(88)90093-9","volume":"26","author":"JG Meechan","year":"1988","unstructured":"Meechan J G, Macgregor I D, Rogers S N et al. The effect of smoking on immediate post-extraction socket filling with blood and on the incidence of painful socket. Br J Oral Maxillofac Surg 1988; 26: 402\u2013409.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"BFsjbdj20095_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jebdp.2005.12.018","volume":"6","author":"J Bergstrom","year":"2006","unstructured":"Bergstrom J. Periodontitis and smoking: an evidence-based appraisal. J Evid Based Dent Pract 2006; 6: 33\u201341.","journal-title":"J Evid Based Dent Pract"},{"key":"BFsjbdj20095_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0039-6060(98)70167-9","volume":"123","author":"LN Jorgensen","year":"1998","unstructured":"Jorgensen L N, Kalehave F, Christensen E et al. Less collagen production in smokers. Surgery 1998; 123: 450\u2013455.","journal-title":"Surgery"},{"key":"BFsjbdj20095_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00223-001-0011-8","volume":"68","author":"T Iwaniec U","year":"2001","unstructured":"Iwaniec U T, Fung Y K, Akhter M P et al. Effects of nicotine on bone mass, turnover and strength in adult female rats. Calcif Tissue Int 2001; 68: 358\u2013364.","journal-title":"Calcif Tissue Int"},{"key":"BFsjbdj20095_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.clinthera.2007.08.008","volume":"29","author":"M Pazianas","year":"2007","unstructured":"Pazianas M, Miller P, Blumentals W A et al. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29: 1548\u20131558.","journal-title":"Clin Ther"},{"key":"BFsjbdj20095_CR21","unstructured":"British National Formulary for children. Section 6.6.2: Bisphosphonates. pp 455\u2013457. London: BMJ Publishing Group Ltd, 2007."},{"key":"BFsjbdj20095_CR22","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black D M, Schwartz A V, Ensrud K E et al. Effects of continuing or stopping alendronate after 5 years of treatment. The fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA 2006; 296: 2927\u20132938.","journal-title":"JAMA"},{"key":"BFsjbdj20095_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.14219\/jada.archive.2008.0002","volume":"139","author":"M Glick","year":"2008","unstructured":"Glick M. Closing in on the puzzle of ONJ. J Am Dent Assoc 2008; 139: 12\u201315.","journal-title":"J Am Dent Assoc"},{"key":"BFsjbdj20095_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007; 65: 415\u2013423.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj20095_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.14219\/jada.archive.2008.0017","volume":"139","author":"JT Grbic","year":"2008","unstructured":"Grbic J T, Landesberg R, Lin S Q et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc 2008; 139: 32\u201340.","journal-title":"J Am Dent Assoc"},{"key":"BFsjbdj20095_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1079-2104(98)90061-0","volume":"85","author":"CB Hermesch","year":"1998","unstructured":"Hermesch C B, Hilton T J, Biesbrock A R et al. Perioperative use of 0.12% chlorhexidine gluconate for the prevention of alveolar osteitis: efficacy and risk factor analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 381\u2013387.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"BFsjbdj20095_CR27","unstructured":"Scottish Intercollegiate Guidelines Network. Antibiotic prophylaxis in surgery. Edinburgh: SIGN, 2000. Guideline 45."},{"key":"BFsjbdj20095_CR28","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"E Marx","year":"2007","unstructured":"Marx E. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007; 65: 2397\u20132410.","journal-title":"J Oral Maxillofac Surg"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2009.5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2009.5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2009.5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:37:38Z","timestamp":1684622258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sj.bdj.2009.5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["BFsjbdj20095"],"URL":"https:\/\/doi.org\/10.1038\/sj.bdj.2009.5","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}